title: Intraportal FK 506 improves intrahepatic islet allograft survival.
authors.affiliation: Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia.
authors.forename: X
authors.initials: X
authors.lastname: Wang
authors.forename: R
authors.initials: R
authors.lastname: Berezniak
authors.forename: L
authors.initials: L
authors.lastname: Tafra
authors.forename: A
authors.initials: A
authors.lastname: Posselt
authors.forename: C F
authors.initials: CF
authors.lastname: Barker
authors.forename: D C
authors.initials: DC
authors.lastname: Dafoe
mesh_terms: D000818:Animals; D001835:Body Weight / Q000187:drug effects; D019819:Budesonide; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000601:surgery*; D005938:Glucocorticoids / Q000627:therapeutic use; D006085:Graft Survival; D007275:Injections, Intravenous; D016381:Islets of Langerhans Transplantation / Q000276:immunology / Q000502:physiology*; D011169:Portal Vein; D011282:Pregnenediones / Q000008:administration & dosage / Q000627:therapeutic use; D051381:Rats; D011917:Rats, Inbred Lew; D011920:Rats, Inbred WF; D016559:Tacrolimus / Q000008:administration & dosage* / Q000627:therapeutic use; D014184:Transplantation, Homologous
chemical_list: D005938:Glucocorticoids; D011282:Pregnenediones; D019819:Budesonide; D016572:Cyclosporine; D016559:Tacrolimus